Advertisement

Topics

Latest "STMicroelectronics Earns MEMS Manufacturer Year Award" News Stories

04:25 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "STMicroelectronics Earns MEMS Manufacturer Year Award" found in our extensive news archives from over 250 global news sources.

More Information about STMicroelectronics Earns MEMS Manufacturer Year Award on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about STMicroelectronics Earns MEMS Manufacturer Year Award for you to read. Along with our medical data and news we also list STMicroelectronics Earns MEMS Manufacturer Year Award Clinical Trials, which are updated daily. BioPortfolio also has a large database of STMicroelectronics Earns MEMS Manufacturer Year Award Companies for you to search.

Showing "STMicroelectronics Earns MEMS Manufacturer Year Award" News Articles 1–25 of 22,000+

Saturday 15th December 2018

SV Veeramani receives 'Industry Crusader Award' at CPhI India 2018 in New Delhi

The immediate past president of the Indian Drugs Manufacturers Association (IDMA) and CMD of the Fourrts India Laboratories, Chennai, S V Veeramani, has been bestowed with the 'Industry Crusader Award'


Pharmaceutical Development is discussed on "Information Matrix" with Laurence Fishburne

An upcoming episode of the popular program will discuss the process of bringing pharmaceuticals to market. FORT LAUDERDALE, Fla. (PRWEB) December 15, 2018 On an upcoming episode of “Information Matrix” opened by Laurence Fishburne, the topic of discussion will be Pharmaceutical Development in the United States. The process of bringing a pharmaceutical drug to the market is a long and often ar...

Twist Bioscience Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryTwist Bioscience Corp Twist Bioscience is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloningready oligo pools; protein scanning single variant libraries, clonal perfect genes and nonclonal fragments, among others. The company operates in the...


Friday 14th December 2018

Novanta Inc NOVT Medical Equipment Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryNovanta Inc Novanta, formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam delivery technologies for electronics, industrial, medical, and scientific applications. Novanta 's techn...

2018: Choice cuts from this year’s News & Views articles

Avery Dennison Corporation AVY Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryAvery Dennison Corporation Avery Dennison is a labeling and packaging materials and solutions provider. The company produces pressuresensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, RFID inlays and tags, and imprinting equipment and related services. It offers products under the brands such as Avery Dennison, ...

Drug Discovery Group encouraged by trials progress

Drug discovery group Evgen Pharma said it was delighted by progress on treatments under development when it announced its interim results for the six months to September 30 today. The AIM-listed business, which has offices in Wilmslow and Liverpool Science Park, focuses on treatments for cancer, strokes and Multiple Sclerosis. It said it released positive interim data from its ongoing clinical stu...

Sorrento Therapeutics Inc SRNE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySorrento Therapeutics Inc STI, formerly QuikByte Software Inc, is a cancer therapeutic service provider. The company offers CD38 CART, lidocaine topical system, resiniferatoxin. Its product pipeline includes CD38 CART, CEA CART, CD38 ADC and seprehvir. STI provides treatment for multiple myeloma, metastatic liver tumors and solid tumors. The company offers therapies for immune oncology, pai...

1-year outcomes of the Xen45 glaucoma implant

The Deadline for Open Enrollment for Health Care Coverage is Saturday, December 15, 2018

WASHINGTON, Dec. 14, 2018 /PRNewswire/ -- This year the Black Women's Health Imperative joined forces with other national organizations to help create awareness and outreach Read more...

Kindred Healthcare Inc KND Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryKindred Healthcare Inc Kindred Healthcare is a healthcare services provider with focus on postacute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operates transitional care TC hospitals, inpatient rehabilitation hospitals IRFs, community care business, assi...

Celltrion Healthcare Co Ltd 091990 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCelltrion Healthcare Co Ltd Celltrion is engaged in distributing, marketing and selling of biosimilar and biological medicines. Its products include Remsima and Truxima. Remsima is a biosimilar monoclonal antibody medication used for autoimmune diseases, including Crohn's disease CD, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. ...

John Laing Group (JLG) - Delivering against guidance

Edison Investment Research - Financials - John Laing Group : John Laing Group’s (JLG’s) pre-close update confirms the strong level of activity in the business in FY18. JLG will provide guidance on the level of realisations and investment commitments expected for FY19 at its results (due March) but we believe the outlook for next year and beyond appears encouraging based on the investme...

Manx Telecom (158355634MANX) - Worth listening out for clearSound

Edison Investment Research - Technology - Manx Telecom: In September, Manx Telecom (MT) subsidiary Goshawk announced the launch of clearSound (MTcS), an innovative mobile phone service for people with hearing needs. Following positive feedback from test groups, MT has signed a deal with BT/EE to launch the Goshawk proposition on their UK networks and it intends invest £10m on the launch over ...

CGI celebrates 20 years on the NYSE

Since its listing on the Big Board in 1998, the stock has appreciated an average of 15% per year, making CGI Canada's largest technology company Read more...

2019 Obamacare Deadline Has Consumers Quickly Enrolling at Local Obamacare Enrollment Center ...

HOLLYWOOD, Fla., Dec. 14, 2018 /PRNewswire/ -- After last year's shock of a 45-day window for Obamacare health plans, consumers were more prepared this time Read more...

FOURIER analysis: Evolocumab lowers LDL cholesterol in most patients

A recent analysis of last year’s FOURIER trial has found evolocumab, a PCSK9 inhibitor developed to treat hyperlipidemia, can robustly reduce low-density lipoprotein cholesterol (LDL-C) in patients without any major concern for individual-level variability in response.

FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia

Application Granted Priority Review Designation Approval Based on Results That Demonstrated Nplate Successfully Increased and Sustained Platelet Counts in Children Affected by Rare Blood Disorder THOUSAND OAKS, Calif., Dec. 14, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...

FDA Approves Treatment for Immune Thrombocytopenia in Children

Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.

Testimony From OxyContin Maker Must Be Unsealed

News Kentucky appeals court says the secret testimony from a former president of a large opioid manufacturer must be released to the public.Contribu

Omnicom Agencies Celebrate 2018 with a Stellar Performance at Campaign Asia Agency of the Year ...

NEW YORK and SINGAPORE, Dec. 14, 2018 /PRNewswire/ -- Omnicom agencies continued their tradition of delivering outstanding creativity and effectiveness by winning 75 Agency of Read more...

Mumbai hospital tells patients to wait until 2020 for MRI

Patients wanting an MRI scan done at Nair Hospital in Mumbai, India, may have to wait until the year 2020 due to the hospital having only one MRI machine in combination with an already long waiting list, according to an article published Dec. 14 by the Hindustan Times.

FDA Approves Romiplostim for Pediatric ITP

The FDA has approved romiplostim for the treatment of pediatric patients aged ≥1 year with immune thrombocytopenia for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.  

PDA Announces Diverse 2019 Board of Directors

PDA's 2019 Board of Directors is one of them of the most diverse boards in the pharmaceutical industry. BETHESDA, Md. (PRWEB) December 14, 2018 The Parenteral Drug Association (PDA) today announced the results of its Board of Directors Election for the term beginning January 1, 2019. In the fall of 2018, PDA’s 10,500 members had an opportunity to participate in the election of new directors...

Applied Genetic Technologies Corp AGTC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryApplied Genetic Technologies Corp AGTC is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as xlinked retinoschisis, achromatopsia, xlinked retinitis pigmentosa, alpha1 antitrypsin deficiency and macular degeneration, among others. AGTC's achromatopsia prov...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks